Convalescent Plasma for COVID-19 Reined In: Chuck Dinerstein, MD, MBA — February 10, 2021
Back in August, the FDA issued an Emergency Use Authorization for convalescent plasma for treating those with COVID-19. With more data in hand, the agency has now limited its use to a subset of hospitalized patients.
“With more data in hand, the agency has now limited its use to a subset of hospitalized patients.”
They are playing the sorcerer’s apprentice. They don’t really have a clue how much of Pandora’s box they are opening.